Sangamo Biosciences: Promising Financial Position and Strategic FDA Alignment Drive Buy Rating
TD Cowen analyst Ritu Baral has maintained their bullish stance on SGMO stock, giving a Buy rating yesterday. Ritu Baral has given her Buy ...